» Articles » PMID: 36267889

The Effects of Augmenting Traditional Rehabilitation with Audio Biofeedback in People with Persistent Imbalance Following Mild Traumatic Brain Injury

Overview
Journal Front Neurol
Specialty Neurology
Date 2022 Oct 21
PMID 36267889
Authors
Affiliations
Soon will be listed here.
Abstract

Complaints of non-resolving imbalance are common in individuals with chronic mild traumatic brain injury (mTBI). Vestibular rehabilitation therapy may be beneficial for this population. Additionally, wearable sensors can enable biofeedback, specifically audio biofeedback (ABF), and aid in retraining balance control mechanisms in people with balance impairments. In this study, we described the effectiveness of vestibular rehabilitation therapy with and without ABF to improve balance in people with chronic mTBI. Participants ( = 31; females = 22; mean age = 40.9 ± 11 y) with chronic (>3 months) mTBI symptoms of self-reported imbalance were randomized into vestibular rehabilitation with ABF ( = 16) or without ABF ( = 15). The intervention was a standard vestibular rehabilitation, with or without ABF, for 45 min biweekly for 6 weeks. The ABF intervention involved a smartphone that provided auditory feedback when postural sway was outside of predetermined equilibrium parameters. Participant's completed the Post-Concussion Symptom Scale (PCSS). Balance was assessed with the sensory organization test (SOT) and the Central Sensorimotor Integration test which measured sensory weighting, motor activation, and time delay with sway evoked by surface and/or visual surround tilts. Effect sizes (Hedge's G) were calculated on the change between pre-and post-rehabilitation scores. Both groups demonstrated similar medium effect-sized decreases in PCSS and large increases in SOT composite scores after rehabilitation. Effect sizes were minimal for increasing sensory weighting for both groups. The with ABF group showed a trend of larger effect sizes in increasing motor activation (with ABF = 0.75, without ABF = 0.22) and in decreasing time delay (with ABF = -0.77, without ABF = -0.52) relative to the without ABF group. Current clinical practice focuses primarily on sensory weighting. However, the evaluation and utilization of motor activation factors in vestibular rehabilitation, potentially with ABF, may provide a more complete assessment of recovery and improve outcomes.

Citing Articles

A review of concurrent sonified biofeedback in balance and gait training.

Zaferiou A, Hirsch Z, Bacani T, Dahl L J Neuroeng Rehabil. 2025; 22(1):38.

PMID: 40011952 PMC: 11866693. DOI: 10.1186/s12984-025-01565-4.


Exploring the Potentials of Wearable Technologies in Managing Vestibular Hypofunction.

Mohammed A, Li S, Liu X Bioengineering (Basel). 2024; 11(7).

PMID: 39061723 PMC: 11274252. DOI: 10.3390/bioengineering11070641.


A Systematic Review of the Long-Term Effects of Using Smartphone- and Tablet-Based Rehabilitation Technology for Balance and Gait Training and Exercise Programs.

Lee C, Ahn J, Lee B Bioengineering (Basel). 2023; 10(10).

PMID: 37892872 PMC: 10604191. DOI: 10.3390/bioengineering10101142.

References
1.
Dozza M, Horak F, Chiari L . Auditory biofeedback substitutes for loss of sensory information in maintaining stance. Exp Brain Res. 2006; 178(1):37-48. DOI: 10.1007/s00221-006-0709-y. View

2.
Alsalaheen B, Mucha A, Morris L, Whitney S, Furman J, Camiolo-Reddy C . Vestibular rehabilitation for dizziness and balance disorders after concussion. J Neurol Phys Ther. 2010; 34(2):87-93. DOI: 10.1097/NPT.0b013e3181dde568. View

3.
Jacobson G, Newman C . The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg. 1990; 116(4):424-7. DOI: 10.1001/archotol.1990.01870040046011. View

4.
Mucha A, Fedor S, DeMarco D . Vestibular dysfunction and concussion. Handb Clin Neurol. 2018; 158:135-144. DOI: 10.1016/B978-0-444-63954-7.00014-8. View

5.
Fleszar Z, Mellone S, Giese M, Tacconi C, Becker C, Schols L . Real-time use of audio-biofeedback can improve postural sway in patients with degenerative ataxia. Ann Clin Transl Neurol. 2019; 6(2):285-294. PMC: 6389757. DOI: 10.1002/acn3.699. View